IRD

Opus Genetics, Inc. Common Stock
IRD

Overview Fund Activity

26 hedge funds and large institutions have $2.62M invested in Opus Genetics, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
26
Holders Change
-2
Holders Change %
-7.14%
% of All Funds
0.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
9
Reduced
5
Closed
6
Calls
$15K
Puts
–
Net Calls
+$15K
Net Calls Change
-$41K

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$244K
2
Northern Trust
Northern Trust
Illinois
+$44.5K
3
UBS Group
UBS Group
Switzerland
+$9.55K
4
NWM
Northwest Wealth Management
Iowa
+$6K
5
Group One Trading
Group One Trading
Illinois
+$5.93K

Top Sellers

1
Citadel Advisors
Citadel Advisors
Florida
-$38K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$37K
3
VF
Virtu Financial
New York
-$30K
4
Bank of America
Bank of America
North Carolina
-$25.5K
5
TSS
Two Sigma Securities
New York
-$24K
Name Holding Trade Value Shares
Change 		Shares
Change %
Susquehanna International Group
26
Susquehanna International Group
Pennsylvania
– -$37K -380 Closed
VF
27
Virtu Financial
New York
– -$30K -305 Closed
TSS
28
Two Sigma Securities
New York
– -$24K -250 Closed
1
2